Home
Dr Reddys Laboratories Ltd EPS

Dr Reddys Laboratories Ltd
NSE: DRREDDY
EPS
Key Highlights
- The Earning per Share of Dr Reddys Laboratories Ltd is ₹ 64.37 as of 27 Feb 25 .
- The earning per share of Dr Reddys Laboratories Ltd changed from ₹ 84.55 to ₹ 16.97 over 7 quarters. This represents a CAGR of -60.05% .
Historical Earning per Share of Dr Reddys Laboratories Ltd
EPS, or Earnings Per Share, is a financial metric that represents the portion of a company's profit allocated to each outstanding share of common stock. It indicates a company's profitability and is calculated by dividing net income by the number of outstanding shares.
Historical Earning per Share of Dr Reddys Laboratories Ltd
Company Fundamentals for Dr Reddys Laboratories Ltd
Market Cap
93,950 Cr
EPS
64.4
P/E Ratio (TTM)
17.5
P/B Ratio (TTM)
3.1
Day’s High
1136.15
Day’s Low
1115.65
DTE
0.2
ROE
17.4
52 Week High
1420.2
52 Week Low
1115.65
ROCE
20.7
Market Price of Dr Reddys Laboratories Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
27 Feb 2025 | 1125.9 |
25 Feb 2025 | 1126.55 |
24 Feb 2025 | 1164.75 |
21 Feb 2025 | 1151.95 |
20 Feb 2025 | 1170.9 |
19 Feb 2025 | 1164.7 |
18 Feb 2025 | 1197.85 |
17 Feb 2025 | 1199.75 |
14 Feb 2025 | 1195.85 |
13 Feb 2025 | 1223.3 |
SWOT Analysis Of Dr Reddys Laboratories Ltd
BlinkX Score for Dr Reddys Laboratories Ltd
Asset Value vs Market Value of Dr Reddys Laboratories Ltd
Market Value
₹ 93,950
Asset Value
Value addition
3.4 X
₹ 21,458
* All values are in ₹ crores
Competitive Comparison of EPS
Company | Market Cap | EPS |
---|
Dr Reddys Laboratories Ltd | 93950 | 64.37 |
Sun Pharmaceuticals Industries Ltd | 395314 | 49.16 |
Divis Laboratories Ltd | 148896 | 77.86 |
Cipla Ltd | 116389 | 61.78 |
Torrent Pharmaceuticals Ltd | 101079 | 55.02 |
Mankind Pharma Ltd | 94641 | 49.48 |
Company | |
---|---|
Dr Reddys Laboratories Ltd | 93950 |
Sun Pharmaceuticals Industries Ltd | 395314 |
Divis Laboratories Ltd | 148896 |
Cipla Ltd | 116389 |
Torrent Pharmaceuticals Ltd | 101079 |
Mankind Pharma Ltd | 94641 |
Historical Market Cap of Dr Reddys Laboratories Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Dr Reddys Laboratories Ltd
Historical Revenue of Dr Reddys Laboratories Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Dr Reddys Laboratories Ltd
Historical EBITDA of Dr Reddys Laboratories Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Dr Reddys Laboratories Ltd
Historical Net Profit of Dr Reddys Laboratories Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Dr Reddys Laboratories Ltd
Dividend Payout Over Time
Dr Reddys Laboratories Ltd News Hub
Dr Reddys Laboratories Ltd gains for third straight session
Dr Reddys Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 707
Read more
21 Aug 24
Dr Reddy's formulations manufacturing units receives EIR from USFDA
Dr Reddys Laboratories has received the Establishment Inspection Report (EIR) for its formulations m
Read more
12 Aug 24
Dr Reddys allots 29,790 equity shares under ESOP
Dr Reddys Laboratories has allotted 29,790 equity shares of Rs.5/- each underlying 29,790 ADRs pursu
Read more
07 Aug 24
Dr Reddy's Labs Andhra Pradesh facility gets EIR from USFDA
The inspection has been classified as voluntary action indicated (VAI) and has been closed according
Read more
06 Sept 24
Document
Concalls
Aug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
TranscriptAug 2024
TranscriptJuly 2024
TranscriptMay 2024
TranscriptFeb 2024
TranscriptNov 2023
TranscriptMay 2023
TranscriptJan 2023
TranscriptNov 2022
TranscriptFeb 2022
TranscriptNov 2021
TranscriptAug 2021
TranscriptMay 2021
Transcript